SEC Form 4 · accession 0001140361-16-073894
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wesley Johnson
Director
Period of report
Jul 27, 2016
Accepted (ET)
Jul 29, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 27, 2016 | A | 5,063 | $0.00 | A | 38,998 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $16.59 | Jul 27, 2016 | A | 5,945 | A | Jul 27, 2017 | Jul 27, 2023 | Common Stock | 5,945 | 5,945 | D |
Explanation of responses
- F1The acquisition of 5,063 shares of common stock represents 5,063 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in three equal installments beginning on 07/27/2017.
- F2Options for 33 1/3% of the shares are each exercisable on 07/27/2017, 07/27/2018 and 07/27/2019, respectively.